The human Fc domain of the hI-con1 may thus potentially activate powerful cytolytic responses mediated by antibody-dependent cell-mediated cytotoxicity against both TF-expressing tumour cells and tumour vascular endothelial cells that bind the hI-con1 molecule. This evidence concerns the gene TF and neoplasm.